What are the side effects of dupixent for asthma?

What side effects do patients report most often with Dupixent for asthma?
Common reactions include injection site pain, redness or swelling, conjunctivitis, and throat pain. Some people also notice cold sores or joint pain during treatment.

How long do these side effects usually last?
Mild injection reactions often fade within a few days. Eye inflammation and joint pain may persist while treatment continues and usually improve after the drug is stopped.

What serious side effects should patients watch for?
Severe allergic reactions, new or worsening eye problems, and signs of blood vessel inflammation such as persistent fever, chest pain, or shortness of breath require immediate medical attention.

Can Dupixent cause breathing problems even though it treats asthma?
Rarely, patients have developed eosinophilic pneumonia or other lung inflammation. Doctors monitor symptoms closely and may pause treatment if breathing worsens.

Why are some patients told to stop Dupixent?
Doctors may discontinue the drug if eye inflammation does not improve, severe allergic reactions occur, or blood tests show abnormal eosinophil levels that suggest organ damage.

Who is more likely to experience side effects?
Patients with a history of eye disease, allergic reactions to other biologics, or those taking additional immunosuppressants appear to have higher rates of adverse events.

How does the side-effect profile compare with other asthma biologics?
Dupixent tends to cause more eye irritation than Nucala or Fasenra, while injection reactions occur at similar rates across these treatments.

When should someone contact their doctor about side effects?
Report any new eye redness, vision changes, persistent joint pain, or signs of infection promptly, because early intervention can prevent complications.

How are side effects managed in practice?
Eye symptoms are often treated with lubricating drops or short courses of steroid eye drops. Injection site reactions are reduced by rotating sites and allowing the syringe to reach room temperature before use.

What ongoing monitoring do patients need?
Regular eye exams and periodic blood work help catch inflammation or eosinophil-related issues early, especially during the first year of therapy.

Sources
[1] https://www.drugpatentwatch.com/drug/dupixent